Kenneth Dale Burman MD
Diabetes, Lipid Metabolism, Thyroid
Professor of Medicine, Georgetown University
Join to View Full Profile
110 Irving St NW# 2A38Washington, DC 20010
Phone+1 202-877-2848
Fax+1 202-877-2322
Dr. Burman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Capital ConsortiumResidency, Internal Medicine, 1972 - 1974
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1970 - 1972
University of Missouri-Columbia School of MedicineClass of 1970
Certifications & Licensure
DC State Medical License 1973 - 2026
MD State Medical License 1994 - 2026
MO State Medical License 1970 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2014
- America's Top Doctors for Cancer Castle Connolly, 2011-2013
- Top Doctors:Washington DC Area Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Sutent Adjunctive Treatment of Differentiated Thyroid Cancer Start of enrollment: 2008 Apr 01
- The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma Start of enrollment: 2012 Sep 01
- Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors Start of enrollment: 2018 Jul 30
Publications & Presentations
PubMed
- 2 citationsInfluence of Thyroglobulin Autoantibodies on Thyroglobulin Levels Measured by Different Methodologies: IMA, LC-MS/MS, and RIA.Ivana Petrovic, Jonathan LoPresti, Shireen Fatemi, Andrew Gianoukakis, Kenneth Burman
The Journal of Clinical Endocrinology and Metabolism. 2024-11-18 - PD-L1 Expression Varies in Thyroid Cancer Types and Is Associated with Decreased Progression Free Survival (PFS) in Patients with Anaplastic Thyroid Cancer.Leila Shobab, Deema Al-Souri, Liza Mathews-Kim, Matthew McCoy, William Kuenstner
Cancers. 2024-10-28 - 1 citationsAssociation of Free Thyroxine with Progression-Free Survival in Intermediate and High Risk Differentiated Thyroid Cancer.Raisa Ghosh, Sungyoung Auh, Sriram Gubbi, Padmasree Veeraraghavan, Craig Cochran
The Journal of Clinical Endocrinology and Metabolism. 2024-08-08
Other
- Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: The Frequency, Sites, Management by Security Agents, and Recommended Phys...Kenneth Burman, MD, Journal of Nuclear Medicine
https://www.doximity.com/articles/39ca59fe-47c4-421e-80bd-73330ab5813e
UpToDate, Wolters Kluwer Health - 2013-01-18 - Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: The Frequency, Sites, Management by Security Agents, and Recommended Phys...Kenneth Burman, MD, Journal of Nuclear Medicine
https://www.doximity.com/articles/39ca59fe-47c4-421e-80bd-73330ab5813e
UpToDate, Wolters Kluwer Health - 2012-07-11 - Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: The Frequency, Sites, Management by Security Agents, and Recommended Phys...Kenneth Burman, MD, Journal of Nuclear Medicine
https://www.doximity.com/articles/39ca59fe-47c4-421e-80bd-73330ab5813e
UpToDate, Wolters Kluwer Health - 2012-04-25 - Join now to see all
Press Mentions
Tackle the Triglycerides to Reduce ASCVD Risk, ACC SaysJuly 28th, 2021
First Thyroid Eye Disease Drug Wins over FDA PanelDecember 13th, 2019
FDA Advisors Recommend CVD Event Reduction Claim for Icosapent EthylNovember 14th, 2019- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
